CareDx, Inc. - Common Stock (CDNA)
23.59
+0.49 (2.12%)
CareDx Inc is a leading company in the field of precision medicine, specializing in organ transplant diagnostics
The company focuses on improving the lives of transplant patients through innovative testing solutions that help monitor and manage the risk of transplant rejection. By leveraging advanced genomic technologies, CareDx develops and commercializes a range of products, including non-invasive tests that analyze the patient's blood to provide critical information about organ health. Their commitment to enhancing patient care and outcomes has established them as a key player in the transplant community.
